|
1
|
Boccaletto P, Machnicka MA, Purta E,
Piatkowski P, Baginski B, WireckI TK, de Crécy-Lagard V, Ross R,
Limbach PA, Kotter A, et al: MODOMICS: A database of RNA
modification pathways. 2017 update. Nucleic Acids Res. 46(D1):
D303–D307. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu ZX, Li LM, Sun HL and Liu SM: Link
between m6A modification and cancers. Front Bioeng Biotechnol.
6:892018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Desrosiers R, Friderici K and Rottman F:
Identification of methylated nucleosides in messenger RNA from
Novikoff hepatoma cells. Proc Natl Acad Sci USA. 71:3971–3975.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dominissini D, Moshitch-Moshkovitz S,
Schwartz S, Salmon- Divon M, Ungar L, Osenberg L, Cesarkas K,
Jacob-Hirsch J, Amariglio N, Kupiec M, et al: Topology of the human
and mouse m6A RNA methylomes revealed by m6A-seq. Nature.
485:201–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kane SE and Beemon K: Precise localization
of m6A in Rous sarcoma virus RNA reveals clustering of methylation
sites: Implications for RNA processing. Mol Cell Biol. 5:2298–2306.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li YL, Yu J and Song SH: Recent progresses
in RNA N6-methyladenosine research. Yi Chuan. 35:1340–1351.
2013.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bokar JA, Rath-Shambaugh ME, Ludwiczak R,
Narayan P and Rottman F: Caracterization and partial purification
of mRNA N6-adenosine methyltransferase from Hela cell nuclei.
Internal mRNA methylation requires a multisubunit complex. J Biol
Chem. 269:17697–17704. 1994.PubMed/NCBI
|
|
8
|
Wu X, Sang L and Gong Y: N6-methyladenine
RNA modification and cancers. Am J Cancer Res. 8:1957–1966.
2018.PubMed/NCBI
|
|
9
|
Alarcón CR, Lee H, Goodarzi H, Halberg N
and Tavazoie SF: N6-methyladenosine marks primary microRNAs for
processing. Nature. 519:482–485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bokar JA, Shambaugh ME, Polayes D, Matera
AG and Rottman FM: Purification and cDNA cloning of the
AdoMet-binding subunit of the human mRNA
(N6-adenosine)-methyltransferase. RNA. 3:1233–1247. 1997.PubMed/NCBI
|
|
11
|
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang
L, Jia G, Yu M, Lu Z, Deng X, et al: A METTL3-METTL14 complex
mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem
Biol. 10:93–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schwartz S, Mumbach MR, Jovanovic M, Wang
T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N,
Cacchiarelli D, et al: Perturbation of m6A writers reveals two
distinct classes of mRNA methylation at internal and 5′ sites. Cell
Rep. 8:284–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Visvanathan A and Somasundaram K: mRNA
traffic control reviewed: N6-methyladenosine (M6A) takes
the driver's seat. Bioessays. 40:2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pendleton KE, Chen B, Liu K, Hunter OV,
Xie Y, Tu BP and Conrad NK: The U6 snRNA m6A
methyltransferase METTL16 regulates SAM synthetase intron
retention. Cell. 169:824–835.e14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang
Y, Yi C, Lindahl T, Pan T, Yang YG and He C: N6-methyladenosine in
nuclear RNA is a major substrate of the obesity-associated FTO. Nat
Chem Biol. 7:885–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng G, Dahl JA, Niu Y, Fedorcsak P,
Huang CM, Li CJ, Vagbo CB, Shi Y, Wang WL, Song SH, et al: ALKBH5
is a mammalian RNA demethylase that impacts RNA metabolism and
mouse fertility. Mol Cell. 49:18–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li A, Chen YS, Ping XL, Yang X, Xiao W,
Yang Y, Sun HY, Zhu Q, Baidya P, Wang X, et al: Cytoplasmic
m6A reader YTHDF3 promotes mRNA translation. Cell Res.
27:444–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN,
Chen ZH, Zeng ZL, Wang F, Zheng J, et al: METTL3 facilitates tumor
progression via an m6A-IGF2BP2-dependent mechanism in
colorectal carcinoma. Mol Cancer. 18:1122019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Chen C, Ding QQ, Zhao Y, Wang ZD,
Chen JJ, Jiang ZR, Zhang Y, Xu GF, Zhang JJ, et al: METTL3-mediated
m6A modification of HDGF mRNA promotes gastric cancer
progression and has prognostic significance. Gut. Oct 3–2019.(Epub
ahead of print).
|
|
20
|
Yue B, Song C, Yang L, Cui R, Cheng X,
Zhang Z and Zhao G: METTL3-mediated N6-methyladenosine modification
is critical for epithelial-mesenchymal transition and metastasis of
gastric cancer. Mol Cancer. 18:1422019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leach RA and Tuck MT: Expression of the
mRNA (N6-adenosine)-methyltransferase S-adenosyl-L-methionine
binding subunit mRNA in cultured cells. Int J Biochem Cell Biol.
33:984–999. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen T, Hao YJ, Zhang Y, Li MM, Wang M,
Han W, Wu Y, Lv Y, Hao J, Wang L, et al: m(6)A RNA methylation is
regulated by microRNAs and promotes reprogramming to pluripotency.
Cell Stem Cell. 16:289–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin S, Choe J, Du P, Triboulet R and
Gregory RI: The m(6)A Methyltransferase METTL3 promotes translation
in human cancer cells. Mol Cell. 62:335–345. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Visvanathan A, Patil V, Arora A, Hegde AS,
Arivazhagan A, Santosh V and Somasundaram K: Essential role of
METTL3- mediated m6A modification in glioma stem-like
cells maintenance and radioresistance. Oncogene. 37:522–533. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barbieri I, Tzelepis K, Pandolfini L, Shi
J, Millán-Zambrano G, Robson SC, Aspris D, Migliori V, Bannister
AJ, Han N, et al: Promoter-bound METTL3 maintains myeloid leukaemia
by m6A-dependent translation control. Nature.
522:126–131. 2017. View Article : Google Scholar
|
|
26
|
Taketo K, Konno M, Asai A, Koseki J,
Toratani M, Satoh T, Doki Y, Mori M, Ishii H and Ogawa K: The
epitranscriptome m6A writer METTL3 promotes chemo- and
radioresistance in pancreatic cancer cells. Int J Oncol.
52:621–629. 2018.PubMed/NCBI
|
|
27
|
Choe J, Lin S, Zhang W, Liu Q, Wang L,
Ramirez-Moya J, Du P, Kim W, Tang S, Sliz P, et al: mRNA
circularization by METTL3-eIF3h enhances translation and promotes
oncogenesis. Nature. 561:556–560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu T, Yang S, Sui J, Xu SY, Cheng YP,
Shen B, Zhang Y, Zhang XM, Yin LH, Pu YP and Liang GY: Dysregulated
N6-methyladenosine methylation writer METTL3 contributes to the
proliferation and migration of gastric cancer. J Cell Physiol.
235:548–562. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du M, Zhang Y, Mao Y, Mou J, Zhao J, Xue
Q, Wang D, Huang J, Gao S and Gao Y: MiR-33a suppresses
proliferation of NSCLC cells via targeting METTL3 mRNA. Biochem
Biophys Res Commun. 482:582–589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin D, Guo J, Wu Y, Du J, Yang L, Wang X,
Di W, Hu B, An J, Kong L, et al: m6A mRNA methylation
initiated by METTL3 directly promotes YAP translation and increases
YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to
induce NSCLC drug resistance and metastasis. J Hematol Oncol.
12:1352019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang
Z, Liu Y, Zhang X, Zhang W and Ye L: HBXIP-elevated
methyltransferase METTL3 promotes the progression of breast cancer
via inhibiting tumor suppressor let-7 g. Cancer Lett. 415:11–19.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wei W, Huo B and Shi X: miR-600 inhibits
lung cancer via downregulating the expression of METTL3. Cancer
Manag Res. 11:1177–1187. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu
HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, et al: METTL3 promote tumor
proliferation of bladder cancer by accelerating pri-miR221/222
maturation in m6A-dependent manner. Mol Cancer. 18:1102019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H,
Wu M, Liang Y, Zhu F, Zhang Y, Zhang X, et al: The m6A
methyltransferase METTL3 promotes bladder cancer progression via
AFF4/NF-κB/MYC signaling network. Oncogene. 38:3667–3680. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peng W, Li J, Chen R, Gu Q, Yang P, Qian
W, Ji D, Wang Q, Zhang Z, Tang J and Sun Y: Upregulated METTL3
promotes metastasis of colorectal cancer via miR-1246/SPRED2/MAPK
signaling pathway. J Exp Clin Cancer Res. 38:3932019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, Tang J, Huang W, Wang F, Li P, Qin
C, Qin Z, Zou Q, WeI J, Hua L, et al: The M6A methyltransferase
METTL3: Acting as a tumor suppressor in renal cell carcinoma.
Oncotarget. 8:96103–96116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Li Y, Toth JI, Petroski MD, Zhang
Z and Zhao JC: N6-methyladenosine modification destabilizes
developmental regulators in embryonic stem cells. Nat Cell Biol.
16:191–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tong J, Flavell RA and Li HB: RNA
m6A modification and its function in diseases. Front
Med. 12:481–489. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Śledź P and Jinek M: Structural insights
into the molecular mechanism of the m(6)A writer complex. Elife.
5:e184342016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang P, Doxtader KA and Nam Y: Structural
basis for cooperative function of Mettl3 and Mettl14
methyltransferases. Mol Cell. 63:306–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang X, Feng J, Xue Y, Guan Z, Zhang D,
Liu Z, Gong Z, Wang Q, Huang J, Tang C, et al: Structural basis of
N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature.
534:575–578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH,
Wang F, Wang TT, Xu QG, Zhou WP and Sun SH: METTL14 suppresses the
metastatic potential of hepatocellular carcinoma by modulating
N6 methyladenosine-dependent primary MicroRNA
processing. Hepatology. 65:529–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu J, Eckert MA, Harada BT, Liu SM, Lu Z,
Yu K, Tienda SM, Chryplewicz A, Zhu AC, Yang Y, et al:
m6A mRNA methylation regulates AKT activity to promote
the proliferation and tumorigenicity of endometrial cancer. Nat
Cell Biol. 20:1074–1083. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gong D, Zhang J, Chen Y, Xu Y, Ma J, Hu G,
Huang Y, Zheng J, ZhaI W and Xue W: The m6A-suppressed
P2RX6 activation promotes renal cancer cells migration and invasion
through ATP-induced Ca2+ Influx Modulating ERK1/2
phosphorylation and MMP9 signaling pathway. J Exp Clin Cancer Res.
38:2332019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen X, Xu M, Xu X, Zeng K, Liu X, Sun L,
Pan B, He B, Pan Y, Sun H, et al: METTL14 suppresses crc
progression via regulating N6-methyladenosine-dependent primary
miR-375 processing. Mol Ther. 28:599–612. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gu C, Wang Z, Zhou N, Li G, Kou Y, Luo Y,
Wang Y, Yang J and Tian F: Mettl14 inhibits bladder TIC
self-renewal and bladder tumorigenesis through
N6-methyladenosine of Notch1. Mol Cancer. 18:1682019.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Little NA, Hastie ND and Davies RC:
Identification of WTAP, a novel Wilms' tumour 1-associating
protein. Hum Mol Genet. 9:2231–2239. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhong S, Li H, Bodi Z, Button J, Vespa L,
Herzog M and Fray RG: MTA is an Arabidopsis messenger RNA adenosine
methylase and interacts with a homolog of a sex-specific splicing
factor. Plant Cell. 20:1278–1288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ping XL, Sun BF, Wang L, Xiao W, Yang X,
Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, et al: Mammalian WTAP is
a regulatory subunit of the RNA N6-methyladenosine
methyltransferase. Cell Res. 24:177–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schöller E, Weichmann F, Treiber T, Ringle
S, Treiber N, Flatley A, Feederle R, Bruckmann A and Meister G:
Interactions, localization, and phosphorylation of the
m6A generating METTL3-METTL14-WTAP complex. RNA.
24:499–512. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen Y, Peng C, Chen J, Chen D, Yang B, He
B, Hu W, Zhang Y, Liu H, Dai L, et al: WTAP facilitates progression
of hepatocellular carcinoma via m6A-HuR-dependent epigenetic
silencing of ETS1. Mol Cancer. 18:1272019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ortega A, Niksic M, Bachi A, Wilm M,
Sánchez L, Hastie N and Valcárcel J: Biochemical function of
female-lethal(2)D/Wilms' tumor suppressor-1-associated proteins in
alternative pre-mRNA splicing. J Biol Chem. 278:3040–3047. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guo J, Tang HW, Li J, Perrimon N and Yan
D: Xio is a component of the Drosophila sex determination pathway
and RNA N6-methyladenosine methyltransferase complex.
Proc Natl Acad Sci USA. 115:3674–3679. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Robinson M, Shah P, Cui YH and He YY: The
role of dynamic m6A RNA methylation in photobiology. Photochem
Photobiol. 95:95–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cheng X, Li M, Rao X, Zhang W, Li XP, Wang
L and Huang G: KIAA1429 regulates the migration and invasion of
hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Onco Targets Ther. 12:3421–3428. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Qian JY, Gao J, Sun X, Cao MD, Shi L, Xia
TS, Zhou WB, Wang S, Ding Q and Wei JF: KIAA1429 acts as an
oncogenic factor in breast cancer by regulating CDK1 in an
N6-methyladenosine-independent Manner. Oncogene. 38:6123–6141.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Frayling TM, Timpson NJ, Weedon MN,
Zeggini E, Freathy RM, Lindgren CM, Perry JRB, Elliott KS, Lango H,
Rayner NW, et al: A common variant in the FTO gene is associated
with body mass index and predisposes to childhood and adult
obesity. Science. 316:889–894. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jia G, Yang CG, Yang S, Jian X, Yi C, Zhou
Z and He C: Oxidative demethylation of 3-methylthymine and
3-methyluracil in single-stranded DNA and RNA by mouse and human
FTO. FEBS Lett. 582:3313–3319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mauer J, Luo X, Blanjoie A, Jiao X,
Grozhik AV, Patil DP, Linder B, Pickering BF, Vasseur JJ, Chen Q,
et al: Reversible methylation of m6Am in the
5′ cap controls mRNA stability. Nature. 541:371–375. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Linder B, Grozhik AV, Olarerin-George AO,
Meydan C, Mason CE and Jaffrey SR: Single-nucleotide-resolution
mapping of m6A and m6Am throughout the transcriptome. Nat Methods.
12:767–772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wei J, Liu F, Lu Z, Fei Q, Ai Y, He PC,
Shi H, Cui X, Su R, Klungland A, et al: Differential
m6A, m6Am, and m1A demethylation
mediated by FTO in the cell nucleus and cytoplasm. Mol Cell.
71:973–985 e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wu WC, Feng J, Jiang D, Zhou X, Jiang Q,
Cai M, Wang X, Shan T and Wang Y: AMPK regulates lipid accumulation
in skeletal muscle cells through FTO-dependent demethylation of
N6-methyladenosine. Sci Rep. 7:416062017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun
L, Wang Y, Li X, Xiong XF, Wei B, et al: RNA N6-methyladenosine
demethylase FTO promotes breast tumor progression through
inhibiting BNIP3. Mol Cancer. 18:462019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li J, Han Y, Zhang H, Qian Z, Jia W, Gao
Y, Zheng H and Li B: The m6A demethylase FTO promotes the growth of
lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem
Biophys Res Commun. 512:479–485. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liu J, Ren D, Du Z, Wang H, Zhang H and
Jin Y: m6A demethylase FTO facilitates tumor progression
in lung squamous cell carcinoma by regulating MZF1 expression.
Biochem Biophys Res Commun. 502:456–464. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Xu D, Shao W, Jiang Y, Wang X, Liu Y and
Liu X: FTO expression is associated with the occurrence of gastric
cancer and prognosis. Oncol Rep. 38:2285–2292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li Y, Zheng D, Wang F, Xu Y, Yu H and
Zhang H: Expression of demethylase gene, FTO and ALKBH1, is
associated with prognosis of gastric cancer. Dig Dis Sci.
64:1503–1513. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C,
Huang H, Nachtergaele S, Dong L, Hu C, et al: FTO plays an
oncogenic role in acute myeloid leukemia as a
N6-methyladenosine RNA demethylase. Cancer Cell.
31:127–141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Su R, Dong L, Li C, Nachtergaele S,
Wunderlich M, Qing Y, Deng X, Wang Y, Weng X, Hu C, et al: R-2HG
exhibits anti-tumor activity by targeting
FTO/m6A/MYC/CEBPA signaling. Cell. 172:90–105.e23. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu
H, Ni T, Zhang ZS, Zhang T, Li C, et al: Small-molecule targeting
of oncogenic Fto demethylase in acute myeloid leukemia. Cancer
Cell. 35:677–691.e10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhou S, Bai ZL, Xia D, Zhao ZJ, Zhao R,
Wang YY and Zhe H: FTO regulates the chemo-radiotherapy resistance
of cervical squamous cell carcinoma (CSCC) by targeting β-catenin
through mRNA demethylation. Mol Carcinog. 57:590–597. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Li J, Zhu L, Shi Y, Liu J, Lin L and Chen
X: m6A demethylase FTO promotes hepatocellular carcinoma
tumorigenesis via mediating PKM2 demethylation. Am J Transl Res.
11:6084–6092. 2019.PubMed/NCBI
|
|
75
|
Yang S, Wei J, Cui YH, Park G, Shah P,
Deng Y, Aplin AE, Lu Z, Hwang S, He C and He YY: m6A
mRNA demethylase FTO regulates melanoma tumorigenicity and response
to anti-PD-1 blockade. Nat Commun. 10:27822019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Aik W, Scotti JS, Choi H, Gong L,
Demetriades M, Schofield CJ and McDonough MA: Structure of human
RNA N6-methyladenine demethylase ALKBH5 provides insights into its
mechanisms of nucleic acid recognition and demethylation. Nucleic
Acids Res. 42:4741–4754. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang C, Samanta D, Lu H, Bullen JW, Zhang
H, Chen I, He X and Semenza GL: Hypoxia induces the breast cancer
stem cell phenotype by HIF-dependent and ALKBH5-mediated
m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA.
113:E2047–E2056. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Nettersheim D, Berger D, Jostes S,
Kristiansen G, Lochnit G and Schorle H: N6-Methyladenosine detected
in RNA of testicular germ cell tumors is controlled by METTL3,
ALKBH5, YTHDC1/F1/F2, and HNRNPC as writers, erasers, and readers.
Andrology. 7:498–506. 2019.PubMed/NCBI
|
|
79
|
Zhang C, Zhi WI, Lu H, Samanta D, Chen I,
Gabrielson E and Semenza GL: Hypoxia-inducible factors regulate
pluripotency factor expression by ZNF217- and ALKBH5-mediated
modulation of RNA methylation in breast cancer cells. Oncotarget.
7:64527–64542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang S, Zhao BS, Zhou A, Lin K, Zheng S,
Lu Z, Chen Y, Sulman EP, Xie K, Bögler O, et al: m6A
demethylase ALKBH5 maintains tumorigenicity of glioblastoma
stem-like cells by sustaining FOXM1 expression and cell
proliferation program. Cancer Cell. 31:591–606 e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
He Y, Hu H, Wang Y, Yuan H, Lu Z, Wu P,
Liu D, Tian L, Yin J, Jiang K and Miao Y: ALKBH5 inhibits
pancreatic cancer motility by decreasing long non-coding RNA
KCNK15-AS1 methylation. Cell Physiol Biochem. 48:838–846. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhang J, Guo S, Piao HY, Wang Y, Wu Y,
Meng XY, Yang D, Zheng ZC and Zhao Y: ALKBH5 promotes invasion and
metastasis of gastric cancer by decreasing methylation of the
lncRNA NEAT1. J Physiol Biochem. 75:379–389. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wang X, Zhao BS, Roundtree IA, Lu Z, Han
D, Ma H, Weng X, Chen K, Shi H and He C: N(6)-methyladenosine
modulates messenger RNA translation efficiency. Cell.
161:1388–1399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu
PJ, Liu C and He C: YTHDF3 facilitates translation and decay of
N6-methyladenosine-modified RNA. Cell Res. 27:315–328.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Xu C, Wang X, Liu K, Roundtree IA, Tempel
W, Li Y, Lu Z, He C and Min J: Structural basis for selective
binding of m6A RNA by the YTHDC1 YTH domain. Nat Chem Biol.
10:927–929. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Tanabe A, Tanikawa K, Tsunetomi M, Takai
K, Ikeda H, Konno J, Torigoe T, Maeda H, Kutomi G, Okita K, et al:
RNA helicase YTHDC2 promotes cancer metastasis via the enhancement
of the efficiency by which HIF-1α mRNA is translated. Cancer Lett.
376:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Patil DP, Chen CK, Pickering BF, Chow A,
Jackson C, Guttman M and Jaffrey SR: m(6)A RNA methylation promotes
XIST-mediated transcriptional repression. Nature. 537:369–373.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhao X, Chen Y, Mao Q, Jiang X, Jiang W,
Chen J, Xu W, Zhong L and Sun X: Overexpression of YTHDF1 is
associated with poor prognosis in patients with hepatocellular
carcinoma. Cancer Biomark. 21:859–868. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Han D, Liu J, Chen C, Dong L, Liu Y, Chang
R, Huang X, Liu Y, Wang J, Dougherty U, et al: Anti-tumour immunity
controlled through mRNA m6A methylation and YTHDF1 in
dendritic cells. Nature. 566:270–274. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kim DJ and Iwasaki A: YTHDF1 control of
dendritic cell cross-priming as a possible target of cancer
immunotherapy. Biochemistry. 58:1945–1946. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Nishizawa Y, Konno M, Asai A, Koseki J,
Kawamoto K, Miyoshi N, Takahashi H, Nishida N, Haraguchi N, Sakai
D, et al: Oncogene c-Myc promotes epitranscriptome m6A
reader YTHDF1 expression in colorectal cancer. Oncotarget.
9:7476–7486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Bai Y, Yang C, Wu R, Huang L, Song S, Li
W, Yan P, Lin C, Li D and Zhang Y: YTHDF1 regulates tumorigenicity
and cancer stem cell-like activity in human colorectal carcinoma.
Front Oncol. 9:3322019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Nguyen TT, Ma LN, Slovak ML, Bangs CD,
Cherry AM and Arber DA: Identification of novel Runx1 (AML1)
translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute
myeloid leukemia. Genes Chromosomes Cancer. 45:918–932. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han
D, Fu Y, Parisien M, Dai Q, Jia G, et al:
N6-methyladenosine-dependent regulation of messenger RNA stability.
Nature. 505:117–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Chen M, Wei L, Law CT, Tsang FH, Shen J,
Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, et al: RNA
N6-methyladenosine methyltransferase-like 3 promotes liver cancer
progression through YTHDF2-dependent posttranscriptional silencing
of SOCS2. Hepatology. 67:2254–2270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Li J, Meng S, Xu M, Wang S, He L, Xu X,
Wang X and Xie L: Downregulation of N6-methyladenosine
binding YTHDF2 protein mediated by miR-493-3p suppresses prostate
cancer by elevating N6-methyladenosine levels.
Oncotarget. 9:3752–3764. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Paris J, Morgan M, Campos J, Spencer GJ,
Shmakova A, Ivanova I, Mapperley C, Lawson H, Wotherspoon DA,
Sepulveda C, et al: Targeting the RNA m6A reader YTHDF2
selectively compromises cancer stem cells in acute myeloid
leukemia. Cell Stem Cell. 25:137–148.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhong L, Liao D, Zhang M, Zeng C, Li X,
Zhang R, Ma H and Kang T: YTHDF2 suppresses cell proliferation and
growth via destabilizing the EGFR mRNA in hepatocellular carcinoma.
Cancer Lett. 442:252–261. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Asano K, Kinzy TG, Merrick WC and Hershey
JW: Conservation and diversity of eukaryotic translation initiation
factor eIF3. J Biol Chem. 272:1101–1109. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Dong Z and Zhang JT: Initiation factor
eIF3 and regulation of mRNA translation, cell growth, and cancer.
Crit Rev Oncol Hematol. 59:169–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
De Benedetti A and Harris AL: eIF4E
expression in tumors: Its possible role in progression of
malignancies. Int J Biochem Cell Biol. 31:59–72. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
De Benedetti A and Graff JR: eIF-4E
expression and its role in malignancies and metastases. Oncogene.
23:3189–3199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Meyer KD, Patil DP, Zhou J, Zinoviev A,
Skabkin MA, Elemento O, Pestova TV, Qian SB and Jaffrey SR: 5′UTR
m(6)A promotes cap-independent translation. Cell. 163:999–1010.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Bachmann F, Banziger R and Burger MM:
Cloning of a novel protein overexpressed in human mammary
carcinoma. Cancer Res. 57:988–994. 1997.PubMed/NCBI
|
|
105
|
Dellas A, Torhorst J, Bachmann F, Bänziger
R, Schultheiss E and Burger MM: Expression of p150 in cervical
neoplasia and its potential value in predicting survival. Cancer.
83:1376–1383. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Wang S, Sun C, Li J, Zhang E, Ma Z, Xu W,
Li H, Qiu M, Xu Y, Xia W, et al: Roles of RNA methylation by means
of N6-methyladenosine (m6A) in human cancers. Cancer
Lett. 408:112–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yang D, Qiao J, Wang G, Lan Y, Li G, Guo
X, Xi J, Ye D, Zhu S, Chen W, et al: N6-methyladenosine
modification of lincRNA 1281 is critically required for mESC
differentiation potential. Nucleic Acids Res. 46:3906–3920. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Liu N, Dai Q, Zheng G, He C, Parisien M
and Pan T: N(6)-methyladenosine-dependent RNA structural switches
regulate RNA-protein interactions. Nature. 518:560–564. 2015.
View Article : Google Scholar : PubMed/NCBI
|
